ARTICLE | Distillery Therapeutics
S100A9 could normalize metabolic imbalances from insulin deficiency
September 10, 2019 12:06 AM UTC
INDICATION: Diabetes...
BCIQ Company Profiles
BCIQ Target Profiles
S100 calcium binding protein A9 (S100A9) (calgranulin B) (MRP14)